Terns Pharmaceuticals (TERN) Change in Acquisitions & Divestments (2020 - 2023)
Terns Pharmaceuticals' Change in Acquisitions & Divestments history spans 4 years, with the latest figure at $52.3 million for Q4 2023.
- For Q4 2023, Change in Acquisitions & Divestments rose 56.11% year-over-year to $52.3 million; the TTM value through Dec 2023 reached $237.8 million, up 102.02%, while the annual FY2025 figure was $107.0 million, 32.1% down from the prior year.
- Change in Acquisitions & Divestments reached $52.3 million in Q4 2023 per TERN's latest filing, up from $41.8 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $92.0 million in Q2 2023 to a low of $8.0 million in Q1 2020.
- Average Change in Acquisitions & Divestments over 4 years is $34.2 million, with a median of $30.8 million recorded in 2022.
- Peak YoY movement for Change in Acquisitions & Divestments: grew 10.68% in 2022, then surged 316.83% in 2023.
- A 4-year view of Change in Acquisitions & Divestments shows it stood at $8.0 million in 2020, then skyrocketed by 68.92% to $13.5 million in 2021, then soared by 148.14% to $33.5 million in 2022, then soared by 56.11% to $52.3 million in 2023.
- Per Business Quant, the three most recent readings for TERN's Change in Acquisitions & Divestments are $52.3 million (Q4 2023), $41.8 million (Q3 2023), and $92.0 million (Q2 2023).